These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 25885651)
21. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]. Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472 [TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483 [TBL] [Abstract][Full Text] [Related]
23. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043 [TBL] [Abstract][Full Text] [Related]
24. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy. Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995 [TBL] [Abstract][Full Text] [Related]
25. Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy. Imoto S; Isaka H; Sakemura N; Ito H; Imi K; Miyamoto K Breast Cancer; 2012 Apr; 19(2):104-9. PubMed ID: 22038672 [TBL] [Abstract][Full Text] [Related]
26. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Yegiyants S; Romero LM; Haigh PI; DiFronzo LA Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977 [TBL] [Abstract][Full Text] [Related]
27. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer. Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737 [TBL] [Abstract][Full Text] [Related]
28. Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients. Gimbergues P; Dauplat MM; Durando X; Abrial C; Le Bouedec G; Mouret-Reynier MA; Cachin F; Kwiatkowski F; Tchirkov A; Dauplat J; Penault-Llorca F Ann Surg Oncol; 2010 Aug; 17(8):2132-7. PubMed ID: 20155400 [TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896 [TBL] [Abstract][Full Text] [Related]
30. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement. Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511 [TBL] [Abstract][Full Text] [Related]
32. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462 [TBL] [Abstract][Full Text] [Related]
33. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node. Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371 [TBL] [Abstract][Full Text] [Related]
34. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Ahlgren J; Holmberg L; Bergh J; Liljegren G Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042 [TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361 [TBL] [Abstract][Full Text] [Related]
36. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681 [TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective. Catzeddu T; Bertelli G; Del Mastro L; Venturini M J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884 [TBL] [Abstract][Full Text] [Related]
38. The accuracy of intraoperative frozen section analysis of the sentinel lymph nodes during breast cancer surgery. Khalifa K; Pereira B; Thomas VA; Mokbel K Int J Fertil Womens Med; 2004; 49(5):208-11. PubMed ID: 15633476 [TBL] [Abstract][Full Text] [Related]
39. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]